Bioverativ Inc (BIVV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 355,600 | 439,600 | 108,600 | -360,300 | -344,600 |
| Depreciation Amortization | 14,500 | 53,400 | 15,600 | 12,300 | 10,600 |
| Income taxes - deferred | -59,500 | -154,200 | N/A | N/A | N/A |
| Accounts receivable | -39,900 | -55,000 | -27,000 | -67,400 | N/A |
| Other Working Capital | 238,200 | -52,500 | -96,000 | -122,200 | -97,000 |
| Other Operating Activity | 81,800 | 70,300 | 40,200 | 81,300 | 12,100 |
| Operating Cash Flow | $590,700 | $301,600 | $41,400 | $-456,300 | $-418,900 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -13,100 | -8,700 | -10,600 | -21,200 | -19,200 |
| Net Acquisitions | -395,700 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | N/A | -26,500 | N/A | -35,100 | N/A |
| Other Investing Activity | 0 | -26,500 | 0 | -35,100 | 0 |
| Investing Cash Flow | $-408,800 | $-35,200 | $-10,600 | $-56,300 | $-19,200 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | -2,600 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 256,200 | -266,400 | -30,800 | 512,600 | 438,100 |
| Financing Cash Flow | $253,600 | $-266,400 | $-30,800 | $512,600 | $438,100 |
| Exchange Rate Effect | 1,000 | N/A | N/A | N/A | N/A |
| End Cash Position | 436,500 | N/A | N/A | N/A | N/A |
| Net Cash Flow | $436,500 | $N/A | $0 | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | 590,700 | 301,600 | 41,400 | -456,300 | -418,900 |
| Capital Expenditure | -13,100 | -8,700 | -10,600 | -21,200 | -19,200 |
| Free Cash Flow | 577,600 | 292,900 | 30,800 | -477,500 | -438,100 |